4 Surprising Ways Popular Weight-Loss Drugs May Affect Your Alcohol Use

Popular drugs such as Ozempic and Wegovy, credited for diabetes and weight loss management, have been shown to be effective in reducing alcohol use. This is according to a small study by the Fralin Biomedical Research Institute at VTC. If you are taking GLP-1 agonists, here’s what you need to know about how they affect how you handle alcohol.

1. They Might Reduce the Alcohol “Buzz”

Researchers found that adults taking GLP-1 weight-loss drugs, including semaglutide medications, showed a slower rise in blood alcohol levels and reported feeling less intoxicated compared to those not on the drugs. Why does this matter? GLP-1s slow the rate at which alcohol enters the bloodstream, reducing the effects of alcohol. A slower uptake means the peak effect of alcohol might happen later or feel less intense.

2. Cravings for Alcohol May Drop

GLP-1s mimic the gut’s natural hormones, signaling the brain to increase feelings of satiety and reduce hunger. These medications also dampen the brain’s reward to sugary foods and other cravings. Research has shown that since semaglutides can affect the brain’s reward system, they can weaken the desire for alcohol craving. In the study, people taking semaglutide drugs reported reduced urges to drink and fewer heavy drinking episodes.

3. This Isn’t a Treatment for Alcohol Use Disorder (Yet)

More than half of the American population consumes alcohol, and about 1 in 10 adults has an alcohol use disorder. Long-term alcohol use is associated with multiple health complications, including liver disease, cancer, and heart disease. Medications for alcohol use reduce drinking by affecting the brain, but GLP-1s seem to do it partially through the gut.

While the effects are interesting, experts caution that these weight-loss drugs are not approved as alcohol-use treatments. More research is needed before they can be used for that purpose.

4. Everyone responds differently

Not everyone on these medications will experience a reduced alcohol buzz or cravings. Individual responses can vary based on health, dosage, and drinking habits. Some experts also argue that the lower reward for alcohol use may lead to increased consumption to compensate. Future research should track overall alcohol consumption and craving patterns over time to determine whether this type of compensation occurs.

Conclusion: Some medications commonly used for weight loss may also dull the effects of alcohol and reduce cravings. However, the research is still in its early stages and does not replace approved treatments for alcohol-related disorders. Even so, the findings point to an intriguing possibility that GLP-1 medications may offer benefits beyond weight loss and diabetes management.

Do you have concerns about your weight? We can help!

Through expertise, Endoslim Clinic of Atlantic Gastroenterology in Brooklyn, New York, can help you navigate your weight management journey with practical solutions. Schedule an online consultation or call us at 718 521-2840 today. Our gastroenterology team will help you achieve optimal outcomes with minimal side effects. 

Share this Article